Lori J. Sokoll
Department of Pathology
Johns Hopkins Medical Institutions
600 North Wolfe Street
Meyer B-125
USA
Name/email consistency: high
- A prospective, multicenter, National Cancer Institute Early Detection Research Network study of [-2]proPSA: improving prostate cancer detection and correlating with cancer aggressiveness. Sokoll, L.J., Sanda, M.G., Feng, Z., Kagan, J., Mizrahi, I.A., Broyles, D.L., Partin, A.W., Srivastava, S., Thompson, I.M., Wei, J.T., Zhang, Z., Chan, D.W. Cancer Epidemiol. Biomarkers Prev. (2010)
- [-2]proenzyme prostate specific antigen for prostate cancer detection: a national cancer institute early detection research network validation study. Sokoll, L.J., Wang, Y., Feng, Z., Kagan, J., Partin, A.W., Sanda, M.G., Thompson, I.M., Chan, D.W. J. Urol. (2008)
- Measurement of parathyroid hormone and application of parathyroid hormone in intraoperative monitoring. Sokoll, L.J. Clin. Lab. Med. (2004)
- Multicenter analytical performance evaluation of the Elecsys proBNP assay. Sokoll, L.J., Baum, H., Collinson, P.O., Gurr, E., Haass, M., Luthe, H., Morton, J.J., Nowatzke, W., Zingler, C. Clin. Chem. Lab. Med. (2004)
- Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men. Sokoll, L.J., Mangold, L.A., Partin, A.W., Epstein, J.I., Bruzek, D.J., Dunn, W., Mohr, P., Wallerson, G., Chan, D.W. Urology (2002)
- Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen. Sokoll, L.J., Bruzek, D.J., Dua, R., Dunn, W., Mohr, P., Wallerson, G., Eisenberger, M., Partin, A.W., Chan, D.W. Urology (2002)
- Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Sokoll, L.J., Drew, H., Udelsman, R. Clin. Chem. (2000)
